제품 수집
제품 세부정보
Synonyms
TNFRSF17, CD269, BCM, BCMA
Source
PE-Labeled Human BCMA, His Tag (BCA-HP2H2) is produced via site-specific conjugation of PE to Human BCMA, His Tag under optimal conditions with a proprietary technology. Human BCMA, His Tag is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ala 54 (Accession # Q02223-1).
Predicted N-terminus: Met 1
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 9.6 kDa.
Conjugate
PE
Excitation Wavelength: 488 nm / 561 nm
Emission Wavelength: 575 nm
Application
Please note that this product is NOT compatible to streptavidin detection system.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, 0.5% BSA, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 6 months under sterile conditions after reconstitution.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
FACS Analysis of Blood Samples
After Fc receptor blockade, the whole blood only control (Figure A) and the whole blood spiked with CAR-T cells (Figures B, C, and D) were first stained with anti-CD45 antibody, anti-CD3 antibody, and PE-labeled Human BCMA/TNFRSF17 Protein, His Tag (Site-specific conjugation) (Cat. BCA-HP2H2), followed by 7-AAD staining. The data were analyzed using FCS Express 7 software (routinely tested). CAR-T cells were identified as PE-positive events within the live CD45⁺CD3⁺ (or CD45⁺) lymphocyte population. In panels B, C, and D, the proportions of CD45⁺ CAR⁺ cells were approximately 20%, 10%, and 1%, respectively, consistent with the theoretical spike‑in values of 22.71%, 11.66%, and 1.17%.
Protocol
Bioactivity-FACS
5e5 of the Anti-BCMA CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human BCMA Protein, His Tag (Cat. No. BCA-HP2H2) and negative control protein respectively, PE signal was used to evaluate the binding activity (QC tested).
Protocol
사용자 리뷰 댓글 남기기
배경 소개
프론티어 진행
의약품 개발 진행- 영어 이름：
B-cell maturation protein
- 카테고리：
- 상장 의약품 수：
8 상세
- 임상 의약품 수：
145 상세
- 최고 개발 단계：
Approved
연락하기
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
신약 후보물질 라이선싱
